2026年全球医疗趋势 保险公司视角 2026 Global Medical Trends Insurer perspective

wtw|TowersWatson

2026Global

MedicalTrends

InsurerperspectiveSurveyreport

Introduction

Thekeyfactorsinfluencing

medicaltrend

rates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spolight

topics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

Aboutthesurvey

>

Aboutthesurvey

Introduction

<2>

TABLEOFCONTENTS

Introduction03

Thekeyfactorsinfluencingmedical04

trendrates

Globalmedicaltrendsbymarket07

Medicaltrendsbymarket12

LatinAmerica12

NorthAmerica14

AsiaPacific15

Europe18

MiddleEastandAfrica21

Factorsdrivingmedicalcosts23

Tariffsandtradepolicies24

Conditionsdrivingmedicalcosts25

Managingmedicalcosts27

Changestomedicalplans29

Spotlighttopics30

Behavioralhealth30

Fertilityandfamilyplanning31

Cancer32

GLP-133

Alinhealthcare34

HowclientsuseinsightsfromGMT35

Calltoaction36

Contacts37

Aboutthesurvey38

Thekeyfactors

influencing

medicaltrend

rates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spolight

topics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

Double-digitglobalmedicalincreasesprojectedtopersistinto2026

Medicalcostsaroundtheworldaresettoriseagainin2026,withaprojectedglobalaverageincreaseof10.3%.Oursurveyfindsthatthissustainedsurgeunderscoresabroaderpatternofrisinghealthcareexpensesthatcontinuetochallengeinsurersandemployersworldwide.

MedicalinflationremainshighestinAsiaPacific,

wherecostincreasesareexpectedtoreach14%

in2026-upfrom13.2%in2025.LatinAmericais

poisedforthesharpestacceleration,jumpingfrom

10.5%in2025to11.9%in2026.TheMiddleEastand

Africaregionisalsoprojectedtoseeacceleration,

withtrendsreaching11.3%in2026.Comparedtothe

sharpincreasesofAsiaPacific,LatinAmericaandthe

MiddleEastandAfrica,NorthAmericaandEuropeare

8.2%in2026,inlinewithexpected2025trends.

forecasttoseemoremodestincreasesof9.2%and

Theseprojectionsunderscoreagrowingsenseof

concernamonginsurers,as56%anticipatefurtherrincreasesinglobalmedicalcosttrendsand55%

expecttheseelevatedlevelstopersistformorethanthreeyears.Thedatasuggeststhatreliefisunlikelyinthenearterm.Asinsurersbraceforprolonged

costpressures,identifyingthekeydriversbehindthesetrendsbecomescriticalforshapingeffectiveresponses.

Highmedicalcosttrendsaredrivenbyregion-specificservicepressures-suchaspharmacy,outpatient,

andprofessionalservices-alongsideglobalstructuralfactorslikenewmedicaltechnologies,pharmaceuticaladvancementsandcondition-basedfactorssuchas

risingcancerincidence,particularlyamongyoungerpopulations.

Figure1:Globalmedicaltrends(gross)2024-2026,globally

andbyregion

2024

2025(expected)

2026(projected)

Globalt

9.5%

10.0%

10.3%

LatinAmericat

9.6%

10.5%

11.9%

NorthAmerica

7.4%

9.4%

9.2%

AsiaPacific

11.8%

13.2%

14.0%

Europet

9.4%

8.3%

8.2%

MiddleEastandAfricat

8.5%

10.3%

11.3%

tGlobl,LatinAmerica,EuropeandMidleEastandAficanumbersexcludeArgentina,Egypt,Nigeria,TurkeyandZimbabweduetovolatiliflaionaryenvironments

Introduction

Thekeyfactors

influencing

medicaltrend

rates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spolight

topics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

Aboutthesurvey

<3>

Thekeyfactorsinfluencingmedicaltrendrates

Whilethetypeofservicedrivingtrendvariesby

region,costincreasesarebeingfeltacrossallareasofcare.IntheAmericas,pharmacycostsareexpectedtoincreasethemostoverthenextyear(Figure2).

PharmacytrendsarealsohighinEuropeandthe

MiddleEastandAfrica,butinpatientservicesarethetopservicedriverinEuropeandoutpatientinthe

MiddleEastandAfrica.InAsiaPacific,professional

services-whichincludephysicianvisits,therapeuticcare,emergencyservices,imaging,labsand

anesthesia-arethefastestgrowingareaintermsofcost.

Suchwideregionalvariationpointstobroad-basedincreasesacrosstheglobe.Theseregionalvariationssuggestmedicalcostinflationisnotisolatedtooneareaofservice,butisaffectingallaspects

ofhealthcare.

Figure2:Servicesdrivingmedicaltrends

Global

Americas

AsiaPacific

Europe

MiddleEastandAfrica

1

Inpatient/HospitalPharmacyProfessionalservicesInpatient/HospitalOutpatient/

10.7%10.5%13.8%9.3%Basicmedica13.4%

2

ProfessionalservicesProfessionalservicesInpatient/HospitalPharmacyPharmacy

10.5%10.1%13.4%9.1%12.7%

3

函

PharmacyInpatient/HospitalOutpatient/ProfessionalservicesInpatient/Hospital

10.4%9.1%Basicmedical8.4%12.3%13.0%

4

Outpatient/Outpatient/PharmacyOutpatient/Professionalservices

BasicmedicalBasicmedical11.7%Basicmedical11.7%

10.2%9.0%8.3%

Note:Percentagesareestimatedmeansofexpectedchangeincostperpersonoverthenextyear

Introduction

Thekeyfactorsinfluencing

medicaltrendrates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spolight

topics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

Aboutthesurvey

<4>

Persistentcostdriversreflectstructuralchallengesacrossglobalhealthcaresystems.Thefactors

contributingtoelevatedmedicalcosttrendsremainlargelyunchanged,withnewmedicaltechnologiescontinuingtoleadglobally-citedby74%ofinsurersastheprimarydriverofcosts(Figure3).

Thisisfollowedbythedeclineofpublichealth

systems(52%)andadvancementsinpharmaceuticals(49%),bothofwhichreflectdeepersystemicshifts

inhealthcaredeliveryandinnovation.Whilefraud,

wasteandabuserankfourthgloballyat38%,itemergesasthetopcostdriverintheMiddleEastandAfrica,

where79%ofinsurersidentifyitasasignificantconcern.

Figure3:Factorsdrivingmedicaltrends

MiddleEastandAfrica

Europe

AsiaPacific

GlobalAmericas

1

Newmedicaltechnologies

Advancementsinpharmaceuticals

Newmedicaltechnologies

Newmedicaltechnologies

Fraud,wasteandabuse

2

Declineofpublichealthsystems

Newmedicaltechnologies

Advancementsinpharmaceuticals

Declineofpublichealthsystems

Newmedicaltechnologies

3

Advancementsinpharmaceuticals

Littleor

nocost-sharing

Littleor

nocost-sharing

Advancementsinpharmaceuticals

Provider/insurerconsolidation

4

Fraud,wasteandabuse

Employee

demographics

Fraud,wasteandabuse

Employee

demographics

Supplychain

disruptions,trade

policies

5

Littleor

nocost-sharing

Declineofpublichealthsystems

Supplychain

disruptions,tradepolicies

Fraud,wasteandabuse

Declineofpublichealthsystems

Introduction

Thekeyfactorsinfluencing

medicaltrendrates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlight

topics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

Aboutthesurvey

<5>

Regionalvariationsinthefactorsdrivingmedical

trendshighlightthediversityofhealthcareneeds

andsystems.IntheAmericas,pharmaceutical

advancementsaretheleadingfactordrivingcosts,

reportedby67%ofinsurers,andranksecondin

AsiaPacificat63%.Thesefiguresareparticularly

relevantintheUnitedStates,wherepharmaceuticalcostsarenotablyhigherduetobroadercoverageofexpensivetherapiessuchasGLP-1drugs—commonlyusedfordiabetesandincreasinglyapprovedfor

obesitytreatment.

CoverageofGLP-1sforobesityisnotcommon

globally,whereonlytwoinfivesayitiscoveredin

anyoftheirplans;theAmericasstandoutwhere

almostthreeinfive(55%)sayitiscovered.However,68%ofinsurersgloballyexpecttheuseofGLP-1swillincrease,particularlyintheAmericas(73%)and

Europe(77%).Alongwithanincreaseinutilization,

thecostsassociatedwithGLP-1sforobesityare

expectedtoincreaseoverthenextthreeyears.

Inthepast,socialprogramshelpedcontrolthecostofcareinEuropeandLatinAmerica,butconsistent

underfundingandotherpressureshaveledtoa

declineinpublichealthsystems,particularlyin

Europeastreatmentsandtheircostsshifttoprivatehealthcareplans.Thedeclineinpublichealthsystemsisreportedasaleadingfactorbythreeinfour(76%)insurersinEurope,thehighestofanyregionglobally.

Canceremergesastheleadingconditiondriving

medicalclaimscostsglobally.Innearlyeveryregion,cancernowstandsasthefastestgrowingandmost

expensivediagnosisforinsurers,citedby57%globally.ThistrendisconsistentintheAmericas(69%),

AsiaPacific(58%)andEurope(54%),wherecancer

isthefastestgrowingconditionintermsofcost.

Incontrast,theMiddleEastandAfricareportdiabetesandmetabolicdiseasesasthefastestgrowing

conditions,with66%ofinsurersnamingtheseasthedominantcostfactor,followedbycancer

at45%.Globally,cardiovascularconditions(50%)andbehavioralhealthissues(37%)arealsogrowingsignificantly,rankingsecondandthirdamongtheconditionsdrivingmedicalclaimscosts.

Therisingburdenofcancerisnotlimitedtoolder

populations.Three-quartersofinsurershave

observedanincreaseincancerincidenceamong

individualsundertheageof40,aligningwithbroaderepidemiologicalfindings.Between1990and2019,

theglobalincidenceofearly-onsetcancerrose

by79.1%,whileearly-onsetcancer-relateddeaths

increasedby27.7%',underscoringthegrowingimpactofthisconditiononyoungerdemographicsand

healthcaresystemsalike.

68%ofinsurersgloballyexpect

theuseofGLP-1swillincrease

¹ZhaoJ,XuL,SunJ,SongM,WangL,YuanS,ZhuY,WanZ,LarssonS.TsilidisK,DunlopM.CampbellH,RudanI,SongP.TheodoratouE,DingK,LiX.Globaltrendsinincidence,death,burdenandriskfactorsofearly-onsetcancerfrom1990to2019.BMJOncol.2023Sep5

Introduction

Thekeyfactorsinfluencing

medicaltrendrates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlighttopics

HowclientsuseinsightsfromGMT

Calltoaction

Contacts

Aboutthesurvey

<6>

Globalmedicaltrendsbymarket

Figure4:Globalmedicaltrends,bymarket

GrossNet^(fromIMFWorldEconomicOutlook)

202420252026202420252026202420252026

Inflationrates

Globalt

9.5

10.0

10.3

6.9

7.4

7.9

2.6

2.6

2.4

LatinAmericat

9.6

10.5

11.9

7.3

7.9

9.2

2.4

2.6

2.7

NorthAmerica

7.4

9.4

9.2

4.5

6.4

6.7

2.9

2.9

2.4

AsiaPacific

11.8

13.2

14.0

9.2

11.0

11.6

2.5

2.2

2.4

Europet

9.4

8.3

8.2

6.9

5.7

6.0

2.5

2.6

2.2

MiddleEastandAfricat

8.5

10.3

11.3

5.2

7.1

8.4

3.3

3.2

2.9

Bymarket

LatinAmerica

Argentina**

208.1

43.6

30.5

-11.8

7.6

16.0

219.9

35.9

14.5

Brazil**

11.7

11.1

11.0

7.3

5.8

6.7

4.4

5.3

4.3

Chile

4.2

5.0

5.7

0.3

0.6

2.5

3.9

4.4

3.2

Colombia**

10.0

10.1

9.5

3.4

5.4

6.4

6.6

4.7

3.1

CostaRica**

11.7

10.4

11.5

12.1

8.3

8.5

-0.4

2.2

3.0

Ecuador

9.9

12.1

13.6

8.3

10.8

12.1

1.5

1.3

1.5

EISalvador

10.5

13.4

15.3

9.5

11.6

13.5

1.0

1.8

1.8

Guatemala

9.5

11.2

11.6

6.6

8.2

7.3

2.9

3.0

4.3

Honduras

8.6

10.4

11.4

4.0

5.6

7.2

4.6

4.7

4.2

Mexico

12.5

13.6

13.5

7.8

10.1

10.3

4.7

3.5

3.2

Nicaragua

4.5

6.5

9.0

-0.1

2.5

5.0

4.6

4.0

4.0

Panama

10.8

8.5

9.8

10.0

8.0

7.8

0.8

0.5

2.0

Peru**

6.7

7.5

9.0

4.3

5.8

7.1

2.4

1.7

1.9

PuertoRico*

10.0

15.0

20.0

8.4

12.9

18.1

1.6

2.1

1.9

TrinidadandTobago

10.0

10.0

10.0

9.5

8.7

8.0

0.5

1.3

2.0

tGlobalLatinAmerica,EuropeandMiddleEastandAfricanumbersexcludeArgentina.Turkey.Egypt,Nigeriaandzimbabweasoutliersduetoinflationarypressures.^Netofgeneralinflation

*CountrieswherethetrendwasprovidedbyWTWbrokers.

**CountrieswherethetrendwasprovidedbybothinsurersandWTWbrokers;thefinalisanaverageofboth.

Introduction

Thekeyfactors

influencing

medicaltrend

rates

Globalmedicaltrends

bymarket

Medicaltrendsbymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditions

driving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlighttopics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

Aboutthesurvey

<〉>

Figure4:Globalmedicaltrends,bymarket

Gross

Net^

Inflationrates

(fromIMFWorldEconomicOutlook)

2024

2025

2026

2024

2025

2026

2024

2025

2026

NorthAmerica

Canada

4.1

5.4

3.6

1.7

3.4

1.5

2.4

2.0

2.1

UnitedStates

7.6

9.7

9.6

4.7

6.7

7.2

3.0

3.0

2.5

AsiaPacific

Australia

6.8

7.6

8.3

3.6

5.1

4.7

3.2

2.6

3.5

Azerbaijan**

4.8

8.5

11.0

2.6

2.8

6.5

2.2

5.7

4.5

Brunei

17.5

25.0

25.0

17.9

24.0

24.0

-0.4

1.0

1.0

China**

11.7

10.6

11.1

11.5

10.6

10.5

0.2

0.0

0.6

HongKong

10.3

9.7

9.9

8.5

7.8

7.7

1.7

1.9

2.2

India**

9.6

11.4

12.9

5.0

7.1

8.8

4.7

4.2

4.1

Indonesia**

12.8

16.9

15.1

10.5

15.2

12.6

2.3

1.7

2.5

Kazakhstan*

10.0

10.0

15.0

1.3

0.1

5.6

8.7

9.9

9.4

Malaysia**

11.7

13.9

15.7

9.9

11.5

13.4

1.8

2.4

2.2

NewZealand**

16.5

16.3

14.9

13.6

14.3

12.9

2.9

2.0

2.0

Pakistan**

22.5

18.5

20.0

-0.9

13.4

12.3

23.4

5.1

7.7

PapuaNewGuinea*

5.0

5.0

5.0

4.4

-0.5

0.4

0.6

5.5

4.6

Philippines**

17.0

14.3

16.1

13.8

11.7

13.2

3.2

2.6

2.9

Singapore**

12.3

15.5

16.9

9.9

14.1

15.4

2.4

1.3

1.5

SouthKorea**

12.6

15.0

13.5

10.3

13.1

11.7

2.3

1.8

1.8

Taiwan

12.7

13.3

16.7

10.5

11.6

15.1

2.2

1.8

1.6

Thailand

9.8

10.8

10.8

9.4

10.1

9.9

0.4

0.7

0.9

Vietnam**

10.3

10.6

12.3

6.7

7.7

9.8

3.6

2.9

2.5

^Netofgeneralinflation

*CountrieswherethetrendwasprovidedbyWTWbrokers.

**CountrieswherethetrendwasprovidedbybothinsurersandWTWbrokers;thefinalisanaverageofboth.

Introduction

Thekeyfactors

influencing

medicaltrend

rates

Globalmedicaltrends

bymarket

Medicaltrendsbymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditionsdriving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlight

topics

HowclientsuseinsightsfromGMT

Calltoaction

Contacts

Aboutthesurvey

<8>

Figure4:Globalmedicaltrends,bymarket

Gross

Net^

Inflationrates

(fromIMFWorldEconomicOutlook)

2024

2025

2026

2024

2025

2026

2024

2025

2026

Europe

Armenia**

5.0

10.8

8.8

4.7

7.5

5.8

0.3

3.2

3.0

Austria

5.0

4.0

5.0

2.1

0.8

3.3

2.9

3.2

1.7

Belgium**

6.8

5.0

4.8

2.4

1.8

2.7

4.3

3.2

2.1

Bulgaria**

19.2

18.3

16.7

16.6

14.6

14.4

2.6

3.7

2.3

Cyprus

5.0

10.0

8.0

2.7

7.7

6.0

2.3

2.3

2.0

Denmark**

4.0

4.5

6.0

2.7

2.6

3.9

1.3

1.9

2.1

Finland*

10.0

15.0

10.0

9.0

13.0

8.0

1.0

2.0

2.0

France**

5.4

6.0

5.9

3.1

4.7

4.3

2.3

1.3

1.6

Georgia

10.8

12.4

13.6

9.7

8.8

10.4

1.1

3.6

3.2

Germany**

9.8

6.1

5.6

7.3

4.0

3.7

2.5

2.1

1.9

Greece**

7.8

7.5

7.7

4.8

5.1

5.6

3.0

2.4

2.1

Hungary**

14.5

11.2

8.4

10.8

6.3

4.9

3.7

4.9

3.6

Ireland**

9.8

7.9

7.3

8.4

6.0

5.6

1.3

1.9

1.7

Italy**

6.5

8.0

10.5

5.4

6.3

8.5

1.1

1.7

2.0

Latvia**

9.2

7.2

9.7

7.8

4.8

7.2

1.3

2.4

2.4

Lithuania**

9.1

7.2

9.9

8.2

3.8

7.1

0.9

3.5

2.8

Netherlands*

5.0

6.5

8.0

1.8

3.7

5.7

3.2

2.8

2.3

Norway**

12.0

10.5

8.1

8.8

7.9

5.9

3.1

2.6

2.2

Poland**

21.8

15.5

14.3

18.1

11.2

10.9

3.7

4.3

3.4

Portugal

12.2

7.6

6.6

9.5

5.7

4.5

2.7

1.9

2.1

Romania**

13.1

12.3

16.1

7.5

7.7

13.0

5.6

4.6

3.1

Serbia**

15.3

8.5

7.8

10.6

4.5

4.4

4.7

4.0

3.3

^Netofgeneralinflation

*CountrieswherethetrendwasprovidedbyWTWbrokers.

**CountrieswherethetrendwasprovidedbybothinsurersandWTWbrokers;thefinalisanaverageofboth.

Introduction

Thekeyfactors

influencing

medicaltrend

rates

Globalmedicaltrends

bymarket

Medicaltrendsbymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditionsdriving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlight

topics

HowclientsuseinsightsfromGMT

Calltoaction

Contacts

Aboutthesurvey

<·>

Figure4:Globalmedicaltrends,bymarket

Gross

Net^

Inflationrates

(fromIMFWorldEconomicOutlook)

2024

2025

2026

2024

2025

2026

2024

2025

2026

Europe

Spain**

7.5

8.8

8.4

4.6

6.6

6.4

2.9

2.2

2.0

Sweden

3.0

3.0

5.0

1.0

0.9

3.0

2.0

2.1

2.0

Turkey**

73.5

48.6

36.7

15.0

12.7

13.9

58.5

35.9

22.8

UnitedKingdom

1.2

10.6

10.0

8.7

7.5

7.8

2.5

3.1

2.2

MiddleEastandAfrica

Algeria

10.0

8.0

8.0

6.0

4.3

4.4

4.0

3.7

3.6

Bahrain**

6.8

9.7

12.3

5.9

8.7

10.8

0.9

1.0

1.5

Benin**

10.8

21.7

20.8

9.7

19.5

18.8

1.2

2.2

2.0

BurkinaFaso**

3.5

6.3

8.0

-0.7

3.3

5.5

4.2

3.0

2.5

Cameroon

19.3

22.0

25.3

14.8

18.6

22.3

4.5

3.4

3.0

Congo(Republicof)**

8.3

10.8

14.3

5.2

7.5

11.1

3.1

3.3

3.2

Coted'lvoire

18.2

14.7

15.8

14.7

11.7

13.6

3.5

3.0

2.2

Egypt**

30.6

29.7

28.1

-2.7

10.0

15.7

33.3

19.7

12.5

Eswatini

6.0

6.0

6.0

2.0

0.8

1.2

4.0

5.2

4.8

Ethiopia

10.0

15.0

25.0

-11.7

-6.5

12.8

21.7

21.5

12.2

Ghana**

19.8

16.0

16.8

-3.0

-1.2

7.4

22.9

17.2

9.4

Guinea*

1.0

1.0

2.0

-7.1

-2.5

-1.0

8.1

3.5

3.0

Iraq*

8.0

5.0

5.0

5.4

2.5

2.3

2.6

2.5

2.7

Jordan**

6.3

10.6

9.9

6.1

7.0

7.3

0.2

3.6

2.6

Kenya**

8.5

8.2

9.5

4.0

4.1

4.6

4.5

4.1

4.9

Kuwait*

3.5

6.3

5.0

0.6

3.8

2.8

2.9

2.5

2.2

Madagascar**

8.6

9.4

9.5

1.0

1.0

2.3

7.6

8.4

7.2

^Netofgeneralinflation

*CountrieswherethetrendwasprovidedbyWTWbrokers.

**CountrieswherethetrendwasprovidedbybothinsurersandWTWbrokers;thefinalisanaverageofboth.

Introduction

Thekeyfactors

influencing

medicaltrend

rates

Globalmedicaltrends

bymarket

Medicaltrendsbymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditionsdriving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlight

topics

HowclientsuseinsightsfromGMT

Calltoaction

Contacts

Aboutthesurvey

<10>

Figure4:Globalmedicaltrends,bymarket

(fromIMFWorldEconomicOutlook)

202420252026202420252026202420252026

GrossNet^

Inflationrates

MiddleEastandAfrica

Mauritius

10.0

15.0

15.0

6.4

11.4

11.4

3.6

3.6

3.6

Morocco*

5.0

5.0

6.0

4.1

2.8

3.7

0.9

2.2

2.3

Niger

5.5

10.8

18.5

-3.6

6.1

15.3

9.1

4.7

3.2

Nigeria**

41.0

53.5

57.5

7.8

27.0

20.5

33.2

26.5

37.0

SaudiArabia

10.1

11.4

13.2

8.4

9.5

11.2

1.7

2.0

2.0

Senegal

10.0

10.0

5.0

9.2

8.0

3.0

0.8

2.0

2.0

SierraLeone

20.0

27.5

35.0

-8.4

14.6

24.6

28.4

12.9

10.4

SouthAfrica**

13.4

13.6

13.7

9.0

9.8

9.1

4.4

3.8

4.5

Tanzania

5.5

6.5

10.0

2.3

2.5

6.0

3.2

4.0

4.0

Togo

6.9

7.5

10.6

3.6

5.2

8.7

3.3

2.3

2.0

Uganda

10.0

9.0

10.0

6.7

4.8

5.3

3.3

4.2

4.7

Zambia

7.0

10.0

10.0

-8.0

-4.2

0.8

15.0

14.2

9.2

Zimbabwe

34.7

34.3

35.0

-701.4

-57.8

25.4

736.1

92.2

9.6

^Netofgeneralinflation

*CountrieswherethetrendwasprovidedbyWTWbrokers.

**CountrieswherethetrendwasprovidedbybothinsurersandWTWbrokers;thefinalisanaverageofboth.

Introduction

Thekeyfactorsinfluencing

medicaltrend

rates

Globalmedicaltrends

bymarket

Medicaltrendsbymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditionsdriving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlight

topics

HowclientsuseinsightsfromGMT

Calltoaction

Contacts

Aboutthesurvey

<">

LatinAmerica

Argentina

Despiteadeclineingeneralinflation,medicalinflationwillremainsignificantlyhighasprivatehealthcare

providerscontinuetoadjusttheirpricesaftermedicalfeeswerederegulatedin2024.OtherdriversoftrendinArgentinaincludetheincreasedcostsofimportedmedicalsuppliesduetocurrencyvolatilty;increaseddemandforhealthcare;andstructuralissuessuchashighhospitaloperatingcosts,wagepressuresand

limitedprovidercompetition.

Cancerremainsamajorcostdriverforprepaid

healthplansinthecountry,asspendingrisesduetotheadoptionofexpensivebiologicsandadvancedtherapies,aswellaslongersurvivalrates.Whiletheuseofbiosimilarshelpsreducecosts,balancing

affordabilityandaccesstocutting-edgetreatmentsremainsachallenge.

Brazil

Chile

TheChileanhealthcaresystemcontinuestoface

significantstructuralchallengesin2025,whichareexpectedtopersistintonextyearandimpactboththepublicandprivatesectors.Risingcostsare

drivenbyfinancialpressuresonthesocialsecurity

system,demographicshiftsandrisingcostsrelatedtotechnologicaladvances.Thishasledtohigher

out-of-pocketexpensesforindividuals,particularlyasyoungerandhealthierinsuredmembersswitchfromtheprivatetothepublicsystem.

Mentalhealthhasbecomeastrategicpriorityin

publicpolicy;however,significantgapsincoverageandaccesspersist,especiallyinruralregionsofthecountry.Additionally,fertilitycoverageisemergingasapolicyfocusduetodemographicchallengesofanagingpopulationandlowbirthrates-currentlyat

1.3childrenperwoman,whichissubstantiallybelowthereplacementrateof2.1.

MedicalcostgrowthinBrazilisprojectedtoslow,

butisstillnearlydoubletherateofgeneralinflation.Keycostdriversincludeanagingpopulation,

mandatorycoverageofnon-contractedprocedures,risingcostsofimportedmedicaltechnologiesandagrowingdemandformentalhealthservices.

Artificialintelligence(Al)isbeingadoptedinhospitalmanagementanddiagnosticstoimproveefficiencyamidongoingproductivitychallengesforhospitalsdespiteincreasedbudgetsoverthepastdecade.

Insurersreportthatmentalhealthtreatmentsaccountfor15%ofmedicalcosts,withmandatorycoverage

forconsultations,hospitalstaysandtherapies.

Mandatoryunlimitedcoverageforautismspectrum

disorder(ASD)hasraisedfinancialandfraudconcerns.CancerdiagnosisandtreatmentinBrazilhave

Aboutthesurvey

Introduction

advancedwithbettertreatmentsavailable,andmanycancertreatmentproceduresarenowincludedintheNationalAgencyforSupplementaryHealth(ANS)list,broadeningaccesstoeffectivetherapies.

Thekeyfactors

influencing

medicaltrend

rates

Globalmedical

trends

bymarket

Medicaltrends

bymarket

Factorsdrivingmedicalcosts

Tariffsand

tradepolicies

Conditionsdriving

medicalcosts

Managing

medicalcosts

Changesto

medicalplans

Spotlight

topics

Howclients

useinsights

fromGMT

Calltoaction

Contacts

《>

LatinAmerica

ColombiaCostaRica

MedicalcostincreasesinColombiaaresettoslowin2026anddespiteoutpacinginflation,thecountrymaintainsoneoftheregion'slowestgrowthrates

inLatinAmerica.Whilethisstabilizationisnotable,costpressurespersistduetoseveralstructuralandexternalfactors,includingpopulationaging,rapid

technologicaladvancements,inflationinthecost

ofinnovativedrugsandongoingpoliticalinstability.Cardiovasculardiseasesareprojectedtosurpass

cancerastheleadingfinancialburden,whilementalhealthcontinuestogrowinimpact.

Mentalhealthandfertilitycoveragearealsogaining

attention,reflectingdemographicshiftsandsocial

demands.Theseimprovementsareencouraging

butinequalitiespersistinthehealthcaresystem,

particularlybetweencontributoryandsubsidized

regimes,withlimitedaccesstoadvancedtreatmentsandpoorinfrastructureinregionsliketheAmazonandCaribbean.

Companiesarerespondingtothesechallengeswithstrategiesfocusedonwellnessprograms,preventivecare,telemedicineanddataanalyticstomanage

costsandimproveemployeeproductivity.Alandnewmedicaltechnologiesplayagrowingroleinimprovingdiagnosticsandtreatmentefficiency,including

useforearlydetectionofcancerandrarediseases,personalizedtreatmentplanningandautomationofservices.

In2026,medicalcostsinCostaRicawillcontinuetoriseduetopopulationaging,increasedincidenceofchronicdiseasesandtheincreasinguseofprivatehealthcareservices.Thisputspressureoninsurers,whofacehigherusage,longertreatmentsandmoreclaimse